A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study
Authors:
- J MantJMJ Mant
- E MurrayEME Murray
- S JowettSJS Jowett
- S BryanSBS Bryan
- J RafteryJRJ Raftery
- M DaviesMDM Davies
- G LipGLG Lip
Open Access
- 1 October 2005
- journal article
- research article
- Published by National Institute for Health and Care Research in Health Technology Assessment
- Vol. 9 (40)
Abstract
Health Technology Assessment Volume: 9, Issue: 40, Published in October 2005Keywords
Funding Information
- Health Technology Assessment Programme (96/22/11)
This publication has 33 references indexed in Scilit:
- Prevalence of Diagnosed Atrial Fibrillation in AdultsJAMA, 2001
- Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillationThe Lancet, 2000
- Prevalence of atrial fibrillation and eligibility for anticoagulants in the communityThe Lancet, 1998
- Cost-effectiveness of Warfarin and Aspirin for Prophylaxis of Stroke in Patients With Nonvalvular Atrial FibrillationJAMA, 1995
- Prevalence, Age Distribution, and Gender of Patients With Atrial FibrillationArchives of internal medicine (1960), 1995
- Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study)The American Journal of Cardiology, 1994
- Sometimes sensitive, seldom specific: A review of the economics of screeningHealth Economics, 1993
- Canadian atrial fibrillation anticoaguiation (CAFA) studyJACC, 1991
- RISK OF STROKE IN NON-RHEUMATIC ATRIAL FIBRILLATIONThe Lancet, 1987
- CARDIORESPIRATORY DISEASE AND DIABETES AMONG MIDDLE-AGED MALE CIVIL SERVANTSThe Lancet, 1974